Palomar Holdings, Inc. (NASDAQ:PLMR) Receives $147.75 Consensus Price Target from Brokerages

Shares of Palomar Holdings, Inc. (NASDAQ:PLMR) have been assigned an average rating of “Moderate Buy” from the six research firms that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $147.75.

Several analysts recently commented on the company. Piper Sandler decreased their price target on Palomar from $151.00 to $132.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. JPMorgan Chase & Co. decreased their price target on Palomar from $160.00 to $150.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 26th. Wall Street Zen lowered Palomar from a “buy” rating to a “hold” rating in a research note on Sunday, March 1st. Zacks Research lowered Palomar from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 15th. Finally, Weiss Ratings raised Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, June 18th.

Insider Buying and Selling at Palomar

In related news, CEO Mac Armstrong sold 3,500 shares of the business’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $112.96, for a total value of $395,360.00. Following the sale, the chief executive officer owned 329,388 shares of the company’s stock, valued at $37,207,668.48. The trade was a 1.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Jon Christianson sold 1,937 shares of the firm’s stock in a transaction on Wednesday, April 15th. The shares were sold at an average price of $128.62, for a total value of $249,136.94. Following the sale, the president directly owned 65,919 shares of the company’s stock, valued at $8,478,501.78. This represents a 2.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 18,634 shares of company stock worth $2,291,441. 3.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Palomar

A number of institutional investors and hedge funds have recently bought and sold shares of PLMR. Royal Bank of Canada boosted its stake in Palomar by 49.1% in the first quarter. Royal Bank of Canada now owns 2,956 shares of the company’s stock worth $406,000 after purchasing an additional 974 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Palomar by 5.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,427 shares of the company’s stock worth $2,115,000 after purchasing an additional 791 shares in the last quarter. NewEdge Advisors LLC acquired a new position in Palomar in the first quarter worth $66,000. United Services Automobile Association acquired a new stake in Palomar in the 1st quarter valued at about $223,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Palomar by 11.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 72,661 shares of the company’s stock valued at $9,960,000 after acquiring an additional 7,754 shares in the last quarter. Institutional investors and hedge funds own 90.25% of the company’s stock.

Palomar Stock Performance

NASDAQ:PLMR opened at $118.91 on Thursday. Palomar has a 12-month low of $100.81 and a 12-month high of $161.35. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $3.15 billion, a PE ratio of 16.56 and a beta of 0.44. The firm has a 50-day moving average price of $115.79 and a 200 day moving average price of $122.36.

Palomar (NASDAQ:PLMR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $2.31 EPS for the quarter, topping analysts’ consensus estimates of $2.17 by $0.14. Palomar had a net margin of 20.11% and a return on equity of 22.62%. The firm had revenue of $278.94 million during the quarter, compared to analysts’ expectations of $557.79 million. During the same quarter last year, the company earned $1.87 earnings per share. The company’s revenue for the quarter was up 59.7% compared to the same quarter last year. Research analysts anticipate that Palomar will post 9.14 earnings per share for the current fiscal year.

Key Headlines Impacting Palomar

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Zacks Research raised its FY2026 earnings estimate for Palomar to $9.87 per share from $8.99, suggesting stronger near-term profit potential. Palomar Holdings analyst update
• Positive Sentiment: Zacks also increased estimates for Q2 2026, Q2 2027, and Q4 2027, which may reinforce expectations that Palomar can sustain earnings growth over time. Palomar Holdings analyst update
• Positive Sentiment: A Zacks article highlighted Palomar as one of the property & casualty insurers positioned to weather the 2026 hurricane season, citing resilient pricing and digitalization trends. Article about P&C insurers poised to weather hurricane season
• Neutral Sentiment: Zacks Research maintained a Hold rating, signaling that analysts see limited short-term upside despite the improved earnings outlook. Palomar Holdings analyst rating
• Neutral Sentiment: Palomar CEO Mac Armstrong sold 3,500 shares under a pre-arranged 10b5-1 plan, a routine insider transaction that may not reflect a change in business fundamentals. SEC insider filing
• Negative Sentiment: Zacks trimmed some future estimates, including Q3 2026, Q1 2027, Q3 2027, and FY2028, which could temper enthusiasm around the pace of Palomar’s growth. Palomar Holdings analyst update

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.